FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...